Incyte To Present At The 32nd Annual Canaccord Genuity Growth Conference

Incyte Corporation (Nasdaq:INCY) announced today it will present at the 32 nd Annual Canaccord Genuity Growth Conference on Wednesday, August 15 at 10:30 a.m. (ET) in Boston.

The presentation will be webcast live and can be accessed at under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 90 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at

Copyright Business Wire 2010